A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

Researchers at the University of Maryland identified a potential link between early-onset ischemic stroke and a genetic ...

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

The ambulance would be the latest addition to Florida’s first mobile stroke treatment unit network, which speeds care to ...

Discover the critical health markers that can help prevent stroke if you have a family history, plus advice on monitoring ...

A report has warned that stroke victims are facing a postcode lottery to access lifesaving treatment. The Stroke Association ...

Blood Test May Detect Stroke Type Before Hospital Arrival, Allowing Faster Treatment Jan. 30, 2025 — People with brain bleeds had nearly 7 times higher blood levels of a specific brain protein ...